Shareholding disclosure

ISOTIS SA

Collectively declared rate

8.74%

Threshold

Crossed upwards

Timeline

Published

23.04.2002

Transaction

—

Voting rights breakdown

Voting rights acquired8.74%

Voting rights sold0%

Below threshold0%

Declared beneficial owners · 2

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

T1421D1391

Beneficial owner

Lombard Odier Immunology Fund

Declared address

Lombard Odier Immunology Fund

Lombard Odier Immunology Fund: 8.02% (1'106'765 Namenaktien) Lombard Odier Opportunity Swiss Small and Mid Caps: 0.72% (100'000 Namenaktien)

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

ISOTIS SA

ISOTIS SA23.04.2002T1421D1391

Disclosure summary

Lombard Odier Immunology Fund disclosed a holding in ISOTIS SA on the acquisition side, published by SIX Exchange Regulation on 23.04.2002, at 8.74% of voting rights. The filing groups 2 beneficial owners declared together. Notice category: Group of shareholders.

Disclosed position

Collectively declared rate

2 people

8.74%

Voting rights acquired

Voting rights acquired8.74%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Declared beneficial owners · 2 people

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Disclosure detail

Lombard Odier Immunology Fund disclosed a holding in ISOTIS SA, published on 23.04.2002.

Publication date23.04.2002

Issuing companyISOTIS SA

Beneficial ownerLombard Odier Immunology Fund

Declared addressLombard Odier Immunology Fund

CategoryGroup of shareholders

Voting rights acquired8.74%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDT1421D1391

Conditions

Lombard Odier Immunology Fund: 8.02% (1'106'765 Namenaktien) Lombard Odier Opportunity Swiss Small and Mid Caps: 0.72% (100'000 Namenaktien)

Source: SIX Exchange Regulation · Publication date: 23.04.2002

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open